• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接力轮次在心脏淀粉样变性准确诊断与管理中的作用

Role of Tag Team Rounds in Accurate Diagnosis and Management of Cardiac Amyloidosis.

作者信息

Wahaj Ahmed, Maqsood Naima, Hassler Jared R, Patil Pravin V, Fabrizio Carly A

机构信息

Rawalpindi Medical University, Rawalpindi, Pakistan.

Section of Cardiology, Temple University Hospital, Philadelphia, Pennsylvania, USA.

出版信息

JACC Case Rep. 2025 Apr 2;30(7):103390. doi: 10.1016/j.jaccas.2025.103390.

DOI:10.1016/j.jaccas.2025.103390
PMID:40185599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12046821/
Abstract

CLINICAL CONDITION

Cardiac Amyloidosis (CA).

KEY QUESTIONS

When should infiltrative cardiomyopathy be suspected, and what is the differential diagnosis? What is the diagnostic yield of a technetium Tc 99m pyrophosphate (Tc-PYP) scan, cardiac magnetic resonance (CMR), and molecular imaging with amyloid positron emission tomography (PET) tracer for CA? Are they able to distinguish between types of CA? What is the diagnostic yield of an endomyocardial biopsy for CA? How is transthyretin amyloid cardiomyopathy (ATTR-CM), treated and what is the prognosis? How do tag team rounds build on the current system of diagnosis and management of CA?

OUTCOME

Tag team rounds between heart failure, pathology, and hematology teams resulted in timely and accurate diagnosis of hereditary ATTR-CM in a patient with new-onset heart failure.

TAKE-HOME MESSAGE: A nonbiopsy diagnosis of CA is more challenging when a monoclonal gammopathy is present. Tag team rounds allow for correct and timely diagnosis of ATTR amyloid when a monoclonal protein is found.

摘要

临床情况

心脏淀粉样变性(CA)。

关键问题

何时应怀疑浸润性心肌病,其鉴别诊断是什么?锝 Tc 99m 焦磷酸盐(Tc-PYP)扫描、心脏磁共振成像(CMR)以及使用淀粉样蛋白正电子发射断层扫描(PET)示踪剂的分子成像对 CA 的诊断阳性率是多少?它们能否区分 CA 的类型?心内膜心肌活检对 CA 的诊断阳性率是多少?转甲状腺素蛋白淀粉样心肌病(ATTR-CM)如何治疗,预后如何?联合查房如何在当前 CA 的诊断和管理系统基础上进行改进?

结果

心力衰竭、病理学和血液学团队之间的联合查房使得一名新发心力衰竭患者的遗传性 ATTR-CM 得到及时、准确的诊断。

要点

当存在单克隆丙种球蛋白病时,CA 的非活检诊断更具挑战性。当发现单克隆蛋白时,联合查房有助于对 ATTR 淀粉样变性进行正确、及时的诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ca/12046821/b3bd6a11062b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ca/12046821/be235b10a29e/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ca/12046821/cda4ea9b57c1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ca/12046821/f3d86b724472/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ca/12046821/890aa781d995/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ca/12046821/30bdb82bda04/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ca/12046821/c60ec5858c1a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ca/12046821/b3bd6a11062b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ca/12046821/be235b10a29e/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ca/12046821/cda4ea9b57c1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ca/12046821/f3d86b724472/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ca/12046821/890aa781d995/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ca/12046821/30bdb82bda04/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ca/12046821/c60ec5858c1a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ca/12046821/b3bd6a11062b/gr6.jpg

相似文献

1
Role of Tag Team Rounds in Accurate Diagnosis and Management of Cardiac Amyloidosis.接力轮次在心脏淀粉样变性准确诊断与管理中的作用
JACC Case Rep. 2025 Apr 2;30(7):103390. doi: 10.1016/j.jaccas.2025.103390.
2
Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with Technetium Pyrophosphate Planar Imaging and Opportunities for Standardization of Diagnostic Workflow.迈向心脏淀粉样变性诊断:焦磷酸盐锝 99m 核素平面显像的单中心经验及诊断工作流程标准化的机遇。
Medicina (Kaunas). 2023 Feb 16;59(2):378. doi: 10.3390/medicina59020378.
3
Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.锝 99m 焦磷酸盐诊断转甲状腺素心脏淀粉样变性:一项不断发展的试验。
JACC Cardiovasc Imaging. 2021 Jun;14(6):1221-1231. doi: 10.1016/j.jcmg.2020.08.027. Epub 2020 Nov 18.
4
Technetium-99m-pyrophosphate imaging-based computed tomography-guided core-needle biopsy of internal oblique muscle in wild-type transthyretin cardiac amyloidosis.基于 99mTc-焦磷酸盐的计算机断层扫描引导下对野生型转甲状腺素蛋白心脏淀粉样变性患者内斜肌进行芯针活检。
Amyloid. 2024 Mar;31(1):12-21. doi: 10.1080/13506129.2023.2235881. Epub 2023 Jul 24.
5
Technetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy.锝焦磷酸盐闪烁扫描术:转甲状腺素淀粉样变心肌病早期诊断的实用指南。
ESC Heart Fail. 2022 Feb;9(1):251-262. doi: 10.1002/ehf2.13693. Epub 2021 Nov 29.
6
Diagnostic value of heart-to-mediastinum ratio in Tc-pyrophospate SPECT/CT for transthyretin cardiac amyloidosis.心肌与纵隔比在 Tc-焦磷酸盐 SPECT/CT 诊断转甲状腺素蛋白心脏淀粉样变性中的价值。
J Nucl Cardiol. 2023 Aug;30(4):1374-1381. doi: 10.1007/s12350-022-03180-5. Epub 2022 Dec 22.
7
Tc Bone-Avid Tracer Cardiac Scintigraphy: Role in Noninvasive Diagnosis of Transthyretin Cardiac Amyloidosis.Tc 骨亲合示踪剂心肌闪烁显像:在转甲状腺素蛋白心脏淀粉样变性的无创性诊断中的作用。
Radiology. 2023 Feb;306(2):e221082. doi: 10.1148/radiol.221082. Epub 2022 Dec 20.
8
Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy.用(99m)锝-焦磷酸显像对心脏淀粉样变性进行成像。
Hell J Nucl Med. 2015 Sep-Dec;18 Suppl 1:42-50.
9
A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report.诊断转甲状腺素蛋白心脏淀粉样变性和核医学中使用锝-99m 焦磷酸盐骨闪烁显像的艰难之路-病例报告。
Med J Malaysia. 2021 Sep;76(5):762-767.
10
Prevalence of transthyretin amyloidosis among heart failure patients with preserved ejection fraction in Japan.日本射血分数保留的心力衰竭患者中甲状腺转运蛋白淀粉样变性的患病率。
ESC Heart Fail. 2023 Jun;10(3):1896-1906. doi: 10.1002/ehf2.14364. Epub 2023 Mar 27.

本文引用的文献

1
National and Regional Medicare Spending on Tafamidis, 2019-2021.2019 - 2021年国家和地区医疗保险对他氟米特的支出情况
JAMA Netw Open. 2024 Sep 3;7(9):e2426086. doi: 10.1001/jamanetworkopen.2024.26086.
2
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.伏硫西汀治疗转甲状腺素蛋白淀粉样变心肌病患者
N Engl J Med. 2025 Jan 2;392(1):33-44. doi: 10.1056/NEJMoa2409134. Epub 2024 Aug 30.
3
Molecular Imaging of Systemic and Cardiac Amyloidosis: Recent Advances and Focus on the Future.全身性和心脏淀粉样变的分子影像学:最新进展及未来展望。
J Nucl Med. 2023 Nov;64(Suppl 2):20S-28S. doi: 10.2967/jnumed.122.264866.
4
2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee.2023年美国心脏病学会关于心脏淀粉样变性患者综合多学科护理的专家共识决策路径:美国心脏病学会解决方案集监督委员会报告
J Am Coll Cardiol. 2023 Mar 21;81(11):1076-1126. doi: 10.1016/j.jacc.2022.11.022. Epub 2023 Jan 23.
5
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging.美国核医学与分子影像学会(ASNC)/美国心脏协会(AHA)/美国超声心动图学会(ASE)/欧洲核医学协会(EANM)/美国心力衰竭学会(HFSA)/美国心律学会(ISA)/心血管磁共振学会(SCMR)/美国核医学与分子影像学会(SNMMI)关于心脏淀粉样变性多模态成像的专家共识建议:第1部分-证据基础和标准化成像方法。
Circ Cardiovasc Imaging. 2021 Jul;14(7):e000029. doi: 10.1161/HCI.0000000000000029. Epub 2021 Jul 1.
6
Diagnostic Performance of Abnormal Nulling on Cardiac Magnetic Resonance Imaging Look Locker Inversion Time Sequence in Differentiating Cardiac Amyloidosis Types.心脏磁共振成像 Look Locker 反转时间序列异常失活在鉴别心脏淀粉样变类型中的诊断性能。
J Thorac Imaging. 2020 Sep;35(5):334-339. doi: 10.1097/RTI.0000000000000493.
7
How to Image Cardiac Amyloidosis: A Practical Approach.如何成像心脏淀粉样变性:实用方法。
JACC Cardiovasc Imaging. 2020 Jun;13(6):1368-1383. doi: 10.1016/j.jcmg.2019.07.015. Epub 2019 Oct 11.
8
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.特发性甲状腺素运载蛋白淀粉样变心肌病患者的塔法米迪治疗。
N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27.
9
Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).前瞻性评估野生型和 V122I 突变转甲状腺素蛋白淀粉样心肌病的发病率和死亡率:转甲状腺素蛋白淀粉样变性心肌病研究(TRACS)。
Am Heart J. 2012 Aug;164(2):222-228.e1. doi: 10.1016/j.ahj.2012.04.015.
10
Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.使用99mTc-3,3-二膦酸-1,2-丙二羧酸闪烁扫描术对心脏淀粉样变性进行无创病因诊断。
J Am Coll Cardiol. 2005 Sep 20;46(6):1076-84. doi: 10.1016/j.jacc.2005.05.073.